• 1
    Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, et al.Bone-marrow transplantation (first of two parts).N Engl J Med1975;292:83243.
  • 2
    Lee SJ, Vogelsang G, Flowers ME.Chronic graft-versus-host disease.Biol Blood Marrow Transplant2003;9:21533.
  • 3
    Van den Bergh V, Tricot G, Fonteyn G, Dom R, Bulcke J.Diffuse fasciitis after bone marrow transplantation.Am J Med1987;83:13943.
  • 4
    Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O, et al.Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases.Ann Intern Med1994;120:9938.
  • 5
    Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al.National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and Staging Working Group report.Biol Blood Marrow Transplant2005;11:94556.
  • 6
    Jacobsohn DA, Chen AR, Zahurak M, Piantadosi S, Anders V, Bolanos-Meade J, et al.Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.J Clin Oncol2007;25:425561.
  • 7
    Carpenter PA.How I conduct a comprehensive chronic graft-versus-host disease assessment.Blood2011;118:267987.
  • 8
    Lee S, Cook EF, Soiffer R, Antin JH.Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.Biol Blood Marrow Transplant2002;8:44452.
  • 9
    Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al.Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.Cancer2000;89:163446.
  • 10
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al.The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.J Clin Oncol1993;11:5709.
  • 11
    McHorney CA, Ware JE Jr, Raczek AE.The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.Med Care1993;31:24763.
  • 12
    Herzberg PY, Heussner P, Mumm FH, Horak M, Hilgendorf I, von Harsdorf S, et al.Validation of the Human Activity Profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2010;16:170717.
  • 13
    Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, et al.Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. IV. Response Criteria Working Group report.Biol Blood Marrow Transplant2006;12:25266.
  • 14
    The Chronic GVHD Consortium.Rationale and design of the Chronic GVHD Cohort Study: improving outcomes assessment in chronic GVHD.Biol Blood Marrow Transplant2011;17:111420.
  • 15
    Waters RL, Lunsford BR, Perry J, Byrd R.Energy-speed relationship of walking: standard tables.J Orthop Res1988;6:21522.
  • 16
    Mathiowetz V, Weber K, Volland G, Kashman N.Reliability and validity of grip and pinch strength evaluations.J Hand Surg Am1984;9:2226.
  • 17
    Fitzmaurice N, Laird N, Ware J.Applied longitudinal analysis.Hoboken (NJ):John Wiley & Sons;2004.
  • 18
    Gardiner JC, Luo Z, Roman LA.Fixed effects, random effects and GEE: what are the differences?Stat Med2009;28:22139.
  • 19
    Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, et al.Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.Blood2011;117:671420.
  • 20
    Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, et al.Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.Blood1988;72:54654.
  • 21
    Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS, et al.Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.Blood1989;74:142835.
  • 22
    Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP, et al.Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.Blood2009;114:7028.
  • 23
    Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM, et al.Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.Blood2011;118:42507.
  • 24
    Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, et al.Incidence, risk factors and outcomes of sclerosis in patients with chronic graft-versus-host disease.Blood2013;121:5098103.
  • 25
    Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, et al.Validation of measurement scales in ocular graft-versus-host disease.Ophthalmology2012;119:48793.
  • 26
    Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, et al.Correlation between NIH composite skin score, patient reported skin score and outcome: results from the Chronic GVHD Consortium.Blood2012;120:254552.